Plasmonic Coupling on an Optical Microfiber Surface: Enabling Single‐Molecule and Noninvasive Dopamine Detection
Advanced Materials · 2023-08 · 35 (33)
DOI: 10.1002/adma.202304116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 08.07.2023. Verfasst von Yunyun Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Optical Fiber Sensing and Communications, Institute of Photonics Technology, Jinan University, Guangzhou, 5111…. Hauptthemen laut MEDLINE: Dopamine, Biosensing Techniques. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Local Innovative and Research Teams.
Abstract (Originalsprache)
Optical fibers can be effective biosensors when employed in early‐stage diagnostic point‐of‐care devices as they can avoid interference from molecules with similar redox potentials. Nevertheless, their sensitivity needs to be improved for real‐world applications, especially for small‐molecule detection. This work demonstrates an optical microfiber biosensor for dopamine (DA) detection based on the DA‐binding‐induced aptamer conformational transitions that occur at plasmonic coupling sites on a double‐amplified nanointerface. The sensor exhibits ultrahigh sensitivity when detecting DA molecules at the single‐molecule level; additionally, this work provides an approach for overcoming optical device sensitivity limits, further extending optical fiber single‐molecule detection to a small molecule range (e.g., DA and metal ions). The selective energy enhancement and signal amplification at the binding sites effectively avoid nonspecific amplification of the whole fiber surface which may lead to false‐positive results. The sensor can detect single‐molecule DA signals in body‐fluids. It can detect the released extracellular DA levels and monitor the DA oxidation process. An appropriate aptamer replacement allows the sensor to be used for the detection of other target small molecules and ions at the single‐molecule level. This technology offers alternative opportunities for developing noninvasive early‐stage diagnostic point‐of‐care devices and flexible single‐molecule detection techniques in theoretical research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Optical Fiber Sensing and Communications, Institute of Photonics Technology, Jinan University, Guangzhou, 511143, China.
- Department of Neurology and Stroke Center, The first Affiliated Hospital, & Clinical Neuroscience Institute, Jinan University, Guangzhou, 510630, China.
ORCID-Profile: Yunyun Huang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Local Innovative and Research Teams
- Guangzhou Science and Technology Plan Project
- Scientific and Technological Innovation Talent of Guangdong
- Cultivation of Guangdong College Students' Scientific and Technological Innovation
Zitieren
APA
Huang, Y., Chen, P., Zhou, L., Zheng, J., Wu, H., Liang, J., Xiao, A., Li, J., & Guan, B. O. (2023). Plasmonic Coupling on an Optical Microfiber Surface: Enabling Single‐Molecule and Noninvasive Dopamine Detection. Advanced Materials, 35(33). https://doi.org/10.1002/adma.202304116
Vancouver
Huang Y, Chen P, Zhou L, Zheng J, Wu H, Liang J, et al. Plasmonic Coupling on an Optical Microfiber Surface: Enabling Single‐Molecule and Noninvasive Dopamine Detection. Advanced Materials. 2023;35(33). doi:10.1002/adma.202304116
BibTeX
@article{Huang2023,
author = {Huang, Yunyun and Chen, Pengwei and Zhou, Luyan and Zheng, Jiaying and Wu, Haotian and Liang, Jiaxuan and Xiao, Aoxiang and Li, Jie and Guan, Bai-Ou},
title = {Plasmonic Coupling on an Optical Microfiber Surface: Enabling Single‐Molecule and Noninvasive Dopamine Detection},
journal = {Advanced Materials},
year = {2023},
volume = {35},
number = {33},
doi = {10.1002/adma.202304116}
}
EUVIMED